Cell Biology Medical Research Clinical Trials Biotechnology Oncology Treatment Immunology Pharmacology Cancer Oncology
The agreement grants Pfizer exclusive development and commercialization rights outside China, with a $1.25 billion upfront payment and potential milestone payouts.